BDBM402289 US10011627, 5

SMILES OC[C@H]1S[C@H]([C@H](O)[C@@H](O)[C@@H]1O)c1ccc(C2CC2)c(Cc2ccc3OCCOc3c2)c1

InChI Key InChIKey=FHRIIRYVXUYDPC-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 402289   

TargetSodium/glucose cotransporter 1(Human)
Youngene Therapeutics

US Patent
LigandPNGBDBM402289(US10011627, 5)
Affinity DataIC50: 4.30nMAssay Description:The following method was used to determine the inhibitory activity of the compounds of the present invention on SGLT1 and SGLT2. The experimental met...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Youngene Therapeutics

US Patent
LigandPNGBDBM402289(US10011627, 5)
Affinity DataIC50: 301nMAssay Description:The following method was used to determine the inhibitory activity of the compounds of the present invention on SGLT1 and SGLT2. The experimental met...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
US Patent